Table 2.
Association between mutation status and sex in melanoma, colon, and lung cancer patients.
| Cancer type | Gen | Status | Men | Women | p | ||
|---|---|---|---|---|---|---|---|
| N | % | N | % | ||||
| Melanoma | BRAF | Wild type | 29 | 55.8 | 34 | 65.4 | |
| Mutated | 23 | 44.2 | 18 | 34.6 | 0.422 | ||
| Colon | KRAS | Wild type | 52 | 51.5 | 47 | 43.9 | 0.341 |
| Mutated | 49 | 48.5 | 60 | 56.1 | |||
| BRAF | Wild type | 91 | 90.1 | 98 | 91.6 | 0.895 | |
| Mutated | 10 | 9.9 | 9 | 8.4 | |||
| PIK3CA | Wild type | 92 | 91.9 | 100 | 93.5 | 0.704 | |
| Mutated | 9 | 8.9 | 7 | 6.5 | |||
| Lung | EGFR | Wild type | 109 | 77.3 | 105 | 65.6 | |
| Mutated | 32 | 22.7 | 55 | 34.4 | 0.035 a | ||
| KRAS | Wild type | 124 | 87.9 | 137 | 85.6 | ||
| Mutated | 17 | 12.1 | 23 | 14.4 | 0.674 | ||
| TP53 | Wild type | 129 | 91.5 | 138 | 86.2 | ||
| Mutated | 12 | 8.5 | 22 | 13.8 | 0.211 | ||
aStatistically significant.